 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Syngenta Makes $518M Offer to Buy Devgen, Boost Access to RNAi Tech for Ag-Bio
September 27, 2012
Syngenta Makes $518M Offer to Buy Devgen, Boost Access to RNAi Tech for Ag-Bio
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- With Thermo Fisher Acquiring Life Tech, RNAi Reagent Space Consolidates Further
April 18, 2013 / Gene Silencing News - Monsanto, Alnylam Form $29.2M Alliance to Apply RNAi to Agriculture
September 6, 2012 / Gene Silencing News - Ag-Bio Firms Increasingly Look to RNAi, microRNAs through Partnerships
May 24, 2012 / Gene Silencing News - Arrowhead Picks Up Drug-Delivery Technology through Alvos Acquisition
April 12, 2012 / Gene Silencing News - RXi Closes Acquisition of Apthera
April 14, 2011 / Gene Silencing News